Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 4Sanofi
02 4AbbVie Inc
03 1Orion Corporation
04 1Strides Pharma Science
05 1ANGENERICO SpA
06 1Abon Pharmaceuticals
07 2Amneal Pharmaceuticals
08 1Apotex Inc
09 1Astam Healthcare
10 1Bahrain Pharma
11 1Chartwell Pharmaceuticals llc
12 1Cosette Pharma
13 2DOC Generici
14 1Genchain Biotech
15 1Glenmark Pharmaceuticals
16 1Hanlim Pharmaceuticals Inc
17 1Hikma Pharmaceuticals
18 1Kolmar Korea Co., Ltd.
19 3LABORATORI BALDACCI SpA
20 2Laboratori Baldacci
21 6Lisapharma Spa
22 1Novell Pharmaceutical Laboratories
23 1ORIFARM GROUP AS
24 1Opes Health Care
25 1PD PARTNERS
26 1Padagis
27 1Pharmascience Inc.
28 2S.F.GROUP Srl
29 2SCHARPER SpA
30 2SF Group
31 2Scharper
32 1Sofar Spa
33 1Solfran Laboratories
34 1Solitaire Pharmacia
35 2Teva Pharmaceutical Industries
36 1Uni-Pharma SA
37 1Vaishali Pharma Ltd
38 1Viatris
39 1Vista Pharmaceuticals
40 1Zydus Lifesciences
01 1Chewable Tablets
02 3Gel
03 3Granules For Oral Suspension
04 1Ml
05 1Oral Powder
06 3SUSPENSION
07 11SUSPENSION;ORAL
08 2Sachet
09 1Sachets
10 4Sucralfate 1.000Mg 40 Combined Oral Use
11 8Sucralfate 2.000Mg 30 Joined' Oral Use
12 1Sucralfate 20% 200Ml Oral Use
13 3Suspension
14 4TABLET
15 5TABLET;ORAL
16 8Tablet
17 2Tablets
01 1DISCN
02 4Generic
03 8Prescription
04 15RX
05 33Blank
01 2ANTEPSIN
02 1APO-SUCRALFATE - TAB 1G
03 1Almiso Tablet
04 5Antepsin
05 2CARAFATE
06 2DEGASTRIL
07 2Degastril
08 1PMS-SUCRALFATE
09 1Peptonorm
10 1Peptovell
11 14SUCRALFATE
12 1SUCRALFATE DOC GENERIC
13 2SUCRALFIN
14 2SUCRAMAL
15 1SUCRAMED
16 1SUCRATES
17 1SULCRATE
18 1SULCRATE SUSPENSION PLUS
19 2Skincol
20 2Sucralfate
21 1Sucralfate Tablets
22 2Sucralfin
23 2Sucramal
24 1Sucrate
25 2Sucrate Gel
26 1Sucroril
27 1Sufad
28 1TEVA-SUCRALFATE
29 1Ulivotina
30 4Blank
01 1Bahrain
02 5Canada
03 1China
04 3Denmark
05 4India
06 1Indonesia
07 27Italy
08 1Mexico
09 2South Korea
10 16USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Sucralfin
Dosage Form : Sucralfate 1.000Mg 40 Combined Oral Use
Dosage Strength : 40 CPR 1 g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : CARAFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1982-01-01
Application Number : 18333
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Denmark
Brand Name : Antepsin
Dosage Form : Tablet
Dosage Strength : 1g
Packaging :
Approval Date : 21-12-1984
Application Number : 28101167883
Regulatory Info : Prescription
Registration Country : Denmark
Synergice, a Strides Pharma initiative, is a new gen B2B platform for diverse portofolio needs.
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2024-05-21
Application Number : 216474
Regulatory Info : RX
Registration Country : USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : Sucralfin
Dosage Form : Sucralfate 2.000Mg 30 Joined' Oral Use
Dosage Strength : os grat 30 bust 2 g
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : SUCRALFIN
Dosage Form : Sachets
Dosage Strength : 2g
Packaging : 30 UNITS 2000 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info :
Registration Country : Italy
Brand Name : SUCRALFIN
Dosage Form : Tablet
Dosage Strength : 1g
Packaging : 40 UNITS 1000 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : CARAFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 1993-12-16
Application Number : 19183
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SULCRATE
Dosage Form : TABLET
Dosage Strength : 1G
Packaging :
Approval Date :
Application Number : 2100622
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : Prescription
Registration Country : Canada
Brand Name : SULCRATE SUSPENSION PLUS
Dosage Form : SUSPENSION
Dosage Strength : 1G/5ML
Packaging :
Approval Date :
Application Number : 2103567
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2019-12-02
Application Number : 209356
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 2022-04-15
Application Number : 215576
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1998-06-08
Application Number : 74415
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2026-01-05
Application Number : 212141
Regulatory Info : RX
Registration Country : USA
Regulatory Info : DISCN
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2024-07-23
Application Number : 212769
Regulatory Info : DISCN
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2025-04-14
Application Number : 211780
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : TABLET;ORAL
Dosage Strength : 1GM
Packaging :
Approval Date : 1996-03-29
Application Number : 70848
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2022-09-12
Application Number : 212913
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2022-03-15
Application Number : 211884
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : SUCRALFATE
Dosage Form : SUSPENSION;ORAL
Dosage Strength : 1GM/10ML
Packaging :
Approval Date : 2024-01-17
Application Number : 213549
Regulatory Info : RX
Registration Country : USA
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
